Acomplaint challenging a claim made by Pfizer in an advertisement for its Viagra Connect erectile dysfunction (ED) drug that “4.3 million men in the UK experience erectile problems” has not been upheld by the UK Advertising Standards Authority (ASA).
Acomplaint challenging a claim made by Pfizer in an advertisement for its Viagra Connect erectile dysfunction (ED) drug that “4.3 million men in the UK experience erectile problems” has not been upheld by the UK Advertising Standards Authority (ASA).
The ASA concluded that the national advertising campaign – which appeared on major UK television channels throughout the summer (OTC...
What's going on with the EU Green Claims Directive? HBW Insight speaks to the European Commission, Parliament and Council to find out why trilogue negotiations seem to have stalled.
Eyelids have the "thinnest, most sensitive skin on the body" and are "highly prone to dehydration," which is why Scope has launched new Optase Life Sensitive Eye Daily Renewal Cream.
P&G provided sufficient support for all challenged claims, including the “Gum Detoxify” brand used on the product label and in advertising on the website and in magazine detail pages.
Pharma Deutschland is one of 21 German associations calling for trilogue negotiations in relation to the EU Green Claims Directive to be suspended while a “comprehensive and independent written impact assessment” is undertaken.
“For us, regulation is the floor, not the ceiling,” Opella's chief sustainability officer Marissa Saretsky tells HBW Insight as the firm gains B Corp Certification. Other topics covered in this exclusive interview include Opella's position on the revised Urban Wastewater Treatment Directive.
Advent International is poised to take control of Reckitt's Essential Home business, but the UK-based firm will retain a 30% stake.
Latest European appointments: Opella names Germany director; Stada has new Western Europe head; Futura makes CEO change.
